Found 130 matching trials
Busulfan, Melphalan, and Thiotepa in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Hodgkin's or Non-Hodgkin's Lymphoma PHASE2 RATIONALE: Chemotherapy, such as busulfan, melphalan, and thiotepa, may des...
Show More Location
Knight Cancer Institute at Oregon Health and Science University
Learn More & Join Trial
Randomized Clinical Study Assessing Haplo vs. URD in AML NA This study compares haplo-identical family donor stem cell transplantation ...
Show More Location
Medical University of Vienna
Learn More & Join Trial
Busulfan and Cyclophosphamide Followed By ALLO BMT NA This is a treatment guideline to allow routine clinical data to be collecte...
Show More Location
Masonic Cancer Center, University of Minnesota
Learn More & Join Trial
Busulfan (BU) Plus Fludarabine Vs Intravenous BU Plus Cyclophosphamide as Conditioning Regimens Prior Allogeneic Hematopoetic Stem Cells Transplant (HSCT) in AML PHASE3 The purpose of this prospective phase III, open-label, randomized multicent...
Show More Location
Chaim Sheba Medical Center
Learn More & Join Trial
Lentiviral Gene Transfer for Treatment of Children Older Than 2 Years of Age With X-Linked Severe Combined Immunodeficiency PHASE1 The purpose of this study is to evaluate the safety and effectiveness of le...
Show More Location
Laboratory of Host Defenses (LHD), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH)
Learn More & Join Trial
Autologous Transplantation for Chronic Myelogenous Leukemia PHASE2 The goal of this clinical research is to learn if treatment with high-dose ...
Show More Location
UT MD Anderson Cancer Center
Learn More & Join Trial
Busulfan and Fludarabine in Patients With AML and MDS PHASE2 Primary Objectives:
1. To administer multiple doses of an intravenous form...
Show More Location
U.T.M.D. Anderson Cancer Center
Learn More & Join Trial
Allogeneic Stem Cell Transplantation in Relapsed/Refractory T-, NK/T-cell Lymphomas PHASE2 Relapsed and refractory T-cell lymphomas have been reported to have dismal ...
Show More Location
Dong-A University
Learn More & Join Trial
BuCy Vs. TBICy for Allo-HSCT in T-ALL Patients PHASE3 T-cell acute lymphoblastic leukemia (T-ALL), a hematological malignant neop...
Show More Location
The First Affiliated Hospital of Soochow University
Learn More & Join Trial
Melphalan and Busulfan Followed By Donor Peripheral Stem Cell Transplant, Tacrolimus, and Methotrexate in Treating Patients With Multiple Myeloma PHASE2 RATIONALE: Giving chemotherapy, such as melphalan and busulfan, before a do...
Show More Location
Fred Hutchinson Cancer Research Center
Learn More & Join Trial